Please use this identifier to cite or link to this item:
Title: Bioavailability and biocompatibility of tetrabranched antifungal peptides.
Authors: Lim, Yih Lin.
Keywords: DRNTU::Science::Biological sciences::Biochemistry
Issue Date: 2012
Abstract: Fungal keratitis is the second leading cause of corneal blindness in the developing countries. Fungal resistance becomes a serious threat in maintaining public health due to the recurrent use of antibiotic therapy. Thus, new therapeutic approach is essential to replace the conventional antibiotics. B4010, a tetrabranched antifungal peptide is developed by Prof. Roger Beuerman’s group at SERI. The aim of this study is to assess the therapeutic potential of B4010 and its four truncated analogues and the scrambled peptide for topical and systemic fungal infections. The antifungal properties of these peptides were tested against 3 C. albicans and their antifungal activities were determined in presence of trypsin (1:100 enzyme: substrate ratio), 25% human serum and 50% tear fluid in vitro. Furthermore, we determined the dissipation of cytoplasmic membrane potential upon adding various peptides to C. albicans ATCC 10231 as well as the haemolytic activity of the peptides in rabbit blood. B4010∆1-5 has evidently shown to be the most effective peptide with low MIC of 12uM and considerably stable in the presence of trypsin, human serum and tear fluid, and exhibit good fungicidal action but strong haemolytic activity. This concludes B4010∆1-5 is the ideal B4010 truncated derivative for further drug-optimization process.
Rights: Nanyang Technological University
Fulltext Permission: restricted
Fulltext Availability: With Fulltext
Appears in Collections:SBS Student Reports (FYP/IA/PA/PI)

Files in This Item:
File Description SizeFormat 
Lim Yih Lin_Final.pdf
  Restricted Access
1.07 MBAdobe PDFView/Open

Page view(s) 50

checked on Sep 27, 2020


checked on Sep 27, 2020

Google ScholarTM


Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.